124 related articles for article (PubMed ID: 1915566)
1. Reserpine-induced reduction of in vivo binding of SCH 23390 and N-methylspiperone and its reversal by d-amphetamine.
Inoue O; Tsukada H; Yonezawa H; Suhara T; Langstrom B
Eur J Pharmacol; 1991 May; 197(2-3):143-9. PubMed ID: 1915566
[TBL] [Abstract][Full Text] [Related]
2. Effect of desipramine on dopamine receptor binding in vivo.
Suhara T; Inoue O; Kobayasi K
Life Sci; 1990; 47(23):2119-26. PubMed ID: 2266782
[TBL] [Abstract][Full Text] [Related]
3. Difference in in vivo receptor binding between [3H]N-methylspiperone and [3H]raclopride in reserpine-treated mouse brain.
Inoue O; Kobayashi K; Tsukada H; Itoh T; Langstrom B
J Neural Transm Gen Sect; 1991; 85(1):1-10. PubMed ID: 1678266
[TBL] [Abstract][Full Text] [Related]
4. Swim stress alters in vivo binding of [3H]N-methylspiperone.
Inoue O; Tsukada H; Kobayashi K; Suhara T; Itoh T
Neuropharmacology; 1991 Oct; 30(10):1101-6. PubMed ID: 1684648
[TBL] [Abstract][Full Text] [Related]
5. Acute reserpine treatment induces down regulation of D-1 dopamine receptor associated adenylyl cyclase activity in rat striatum.
Thomas KL; Rose S; Jenner P; Marsden CD
Biochem Pharmacol; 1992 Jul; 44(1):83-91. PubMed ID: 1321631
[TBL] [Abstract][Full Text] [Related]
6. Adaptive mechanisms of striatal D1 and D2 dopamine receptors in response to a prolonged reserpine treatment in mice.
Rubinstein M; Muschietti JP; Gershanik O; Flawia MM; Stefano FJ
J Pharmacol Exp Ther; 1990 Feb; 252(2):810-6. PubMed ID: 2138223
[TBL] [Abstract][Full Text] [Related]
7. Effect of L-dopa and reserpine on in vivo binding of (3H)-SCH 23390 and (3H)-N-methylspiperone.
Yonezawa H; Inoue O; Tsukada H; Suhara T; Itoh T; Tohgi H; Yamasaki T; Långström B
Acta Radiol Suppl; 1991; 376():167-8. PubMed ID: 1687191
[No Abstract] [Full Text] [Related]
8. Effects of endogenous dopamine on kinetics of [3H]N-methylspiperone and [3H]raclopride binding in the rat brain.
Young LT; Wong DF; Goldman S; Minkin E; Chen C; Matsumura K; Scheffel U; Wagner HN
Synapse; 1991 Nov; 9(3):188-94. PubMed ID: 1776131
[TBL] [Abstract][Full Text] [Related]
9. Effects of reserpine treatment on the dopamine receptor binding of [3H/11C]nemonapride in the mouse and rat brain.
Ishiwata K; Onoguchi K; Toyama H; Noguchi J; Senda M
Ann Nucl Med; 1997 Feb; 11(1):21-6. PubMed ID: 9095318
[TBL] [Abstract][Full Text] [Related]
10. Amphetamine-stimulated dopamine release competes in vivo for [123I]IBZM binding to the D2 receptor in nonhuman primates.
Innis RB; Malison RT; al-Tikriti M; Hoffer PB; Sybirska EH; Seibyl JP; Zoghbi SS; Baldwin RM; Laruelle M; Smith EO
Synapse; 1992 Mar; 10(3):177-84. PubMed ID: 1532675
[TBL] [Abstract][Full Text] [Related]
11. In vivo binding of 3H-N-methylspiperone to dopamine and serotonin receptors.
Frost JJ; Smith AC; Kuhar MJ; Dannals RF; Wagner HN
Life Sci; 1987 Mar; 40(10):987-95. PubMed ID: 3821368
[TBL] [Abstract][Full Text] [Related]
12. Striatal D1- and D2-dopamine receptor sites are separately detectable in vivo.
Leslie CA; Bennett JP
Brain Res; 1987 Jul; 415(1):90-7. PubMed ID: 2957025
[TBL] [Abstract][Full Text] [Related]
13. In vivo binding of spiperone and N-methylspiperone to dopaminergic and serotonergic sites in the rat brain: multiple modeling and implications for PET scanning.
Swart JA; van der Werf JF; Wiegman T; Paans AM; Vaalburg W; Korf J
J Cereb Blood Flow Metab; 1990 May; 10(3):297-306. PubMed ID: 1970341
[TBL] [Abstract][Full Text] [Related]
14. Effects of chronic antidepressant treatment on dopamine-related [3H]SCH 23390 and [3H]spiperone binding in the rat striatum.
Paetsch PR; Greenshaw AJ
Cell Mol Neurobiol; 1992 Dec; 12(6):597-606. PubMed ID: 1490276
[TBL] [Abstract][Full Text] [Related]
15. Identification and characterization of D1 and D2 dopamine receptors in cultured neuroblastoma and retinoblastoma clonal cell lines.
Monsma FJ; Brassard DL; Sibley DR
Brain Res; 1989 Jul; 492(1-2):314-24. PubMed ID: 2665904
[TBL] [Abstract][Full Text] [Related]
16. Reserpine-induced up-regulation of dopamine D2 receptors in the rat striatum is enhanced by denervation but not by chronic receptor blockade.
Traub M; Reches A; Wagner HR; Fahn S
Neurosci Lett; 1986 Oct; 70(2):245-9. PubMed ID: 2946007
[TBL] [Abstract][Full Text] [Related]
17. A PET study of D(1)-like dopamine receptor ligand binding during altered endogenous dopamine levels in the primate brain.
Chou YH; Karlsson P; Halldin C; Olsson H; Farde L
Psychopharmacology (Berl); 1999 Sep; 146(2):220-7. PubMed ID: 10525759
[TBL] [Abstract][Full Text] [Related]
18. In vivo striatal binding of the D1 antagonist SCH 23390 is not modified by changes in dopaminergic transmission.
Thibaut F; Vaugeois JM; Bonnet JJ; Costentin J
Neuropharmacology; 1996 Mar; 35(3):267-72. PubMed ID: 8783200
[TBL] [Abstract][Full Text] [Related]
19. Dopamine D1 receptor and dopamine D2 receptor binding activity changes during chronic administration of nicotine in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice.
Wiener HL; Lajtha A; Sershen H
Neuropharmacology; 1989 May; 28(5):535-7. PubMed ID: 2657481
[TBL] [Abstract][Full Text] [Related]
20. Differential recovery rates of rat D2 dopamine receptors as a function of aging and chronic reserpine treatment following irreversible modification: a key to receptor regulatory mechanisms.
Norman AB; Battaglia G; Creese I
J Neurosci; 1987 May; 7(5):1484-91. PubMed ID: 2952771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
